The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in revenue , its intellectual property lapse created a https://thebookmarkage.com/story21388186/viagra-and-big-pharma-a-risky-opportunity